Effects of Atomoxetine on Cognitive Function in Schizophrenia

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

September 30, 2007

Conditions

SchizophreniaCognitionSmoking

Interventions

DRUG

Atomoxetine (Strattera™)

Trial Locations (1)

Connecticut Mental Health Center, SAC-115, New Haven

All Listed Sponsors

collaborator

National Alliance for Research on Schizophrenia and Depression

OTHER

lead

Yale University

OTHER

NCT00420498 - Effects of Atomoxetine on Cognitive Function in Schizophrenia | Biotech Hunter | Biotech Hunter